The Maintenance Treatment of "ITIVA" in AML Patients

Clinical trial NCT06256627 · RECRUITING

Trial details

NCT number: NCT06256627
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Maintenance Treatment Minor Residue Disease Interferon-α-1b Interleukin-2 Thalidomide Venentoclax Azacitidine

Start date: 2023-07-11
Primary completion: 2025-03-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.